Dr John Nash, Senior Director ADME/PK, BioFocus
November 3, 2009Research and Development appointment, biofocus, research and development
BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK. John has …
Phase III success for GSK’s lupus drug
November 3, 2009Research and Development, Sales and Marketing Benlysta, GSK
GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …
Whatever happened to yesterday’s ‘magic bullets’?
November 3, 2009Research and Development Les Rose, biotech
How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …
Fast times at contract research firm PPD
November 3, 2009Research and Development CRO
Pharmaceutical Product Development (PPD) has unveiled several new initiatives to re-inject some growth momentum into the business as its third-quarter …
UK lung cancer patients face ‘unacceptable postcode lottery’
November 3, 2009NHS
Lung cancer patients in the UK face an "unacceptable postcode lottery", according to the first national review of lung cancer …
GSK-Genmab blood cancer drug approved in US
November 2, 2009Research and Development, Sales and Marketing Arzerra
GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …
Lonza cuts staff, issues profits warning
November 2, 2009Manufacturing and Production CMO
Swiss contract manufacturer and fine chemical firm Lonza has announced it will cut around 5% of its workforce and may …
Jackie Ilacqua, head of oncology, Synovate
November 2, 2009Sales and Marketing appointment, sales and marketing, synovate
Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.Formerly responsible for building and managing Synovate’s global …
AstraZeneca withdraws filings for lung cancer drug
November 2, 2009Research and Development, Sales and Marketing AZ, zactima
AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …
GSK returns to growth despite US sales hit
October 28, 2009Sales and Marketing GSK, generics
GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …
GSK begins phase III COPD trials
October 28, 2009Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory
GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
Claude Bertrand joins Ipsen as Chief Scientific Officer
October 27, 2009Research and Development appointment, ipsen, research and development
Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …
Merck KGaA’s rising revenues fail to lift bottom line
October 27, 2009Sales and Marketing Merck Serono
Revenues up, earnings down: that was the bottom line to Merck KGaA’s financial performance in the three months to the …
Quintiles will open new clinical unit in London next year
October 27, 2009Research and Development NHS, Quintiles
Quintiles has agreed to set up a clinical research unit in London that will allow it to tap into the …
New digital agency eBee launched
October 27, 2009Medical Communications digi pharma
New agency eBee has been launched as a specialist in groundbreaking digital work.The agency is a spin-off subsidiary of Hive …
Consolidation wave likely to continue among European CROs
October 27, 2009Research and Development cros
Another report concluding that the most successful contract research organisations (CROs) will be those that can offer a broad range …
Contract research news in brief
October 26, 2009Research and Development cros
Pharmafocus' round-up of contract research news includes ICON's Q3 results, expansion plans at ClinTec and a prestigious award for Bilcare
Critical Pharma gets Wellcome funding for biologic spray technology
October 26, 2009Research and Development critical pharma
A nasal spray technology which promises an alternative drug delivery method for biologic drugs has been given a funding boost. …
Adventis Health appoints five new staff
October 26, 2009Medical Communications Adventis, appointment, medical communications
Adventis Health has appointed five new staff – three to its med ed division, one to its advertising division and …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
